VolitionRx Limited (VNRX) Total liabilities 2019–2025
VolitionRx Limited (VNRX) total liabilities at each fiscal year-end, per SEC filings.
$42.5MFY2025 · since FY2019: $7.1M → $42.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $42.5M | +19.7% |
| FY2024 | $35.5M | -3.2% |
| FY2023 | $36.7M | +71.1% |
| FY2022 | $21.4M | +119.3% |
| FY2021 | $9.8M | -0.9% |
| FY2020 | $9.9M | +39.0% |
| FY2019 | $7.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More VNRX financial trends
VNRX RevenueVNRX Net incomeVNRX Net marginVNRX Gross profitVNRX Gross marginVNRX Operating incomeVNRX Operating marginVNRX Operating cash flowVNRX Free cash flowVNRX Capital expendituresVNRX Return on equityVNRX Stock buybacksVNRX Dividends paidVNRX Total assetsVNRX Shareholders’ equityVNRX overview →